UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000035794
Receipt number R000040776
Scientific Title A study to reveal the actual clinical features of chronic constipation and to evaluate the efficacy of therapeutic drugs on chronic constipation
Date of disclosure of the study information 2019/02/13
Last modified on 2023/02/09 12:43:27

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

A study to reveal the actual clinical features of chronic constipation and to evaluate the efficacy of therapeutic drugs on chronic constipation

Acronym

A study to reveal the actual clinical features of chronic constipation and to evaluate the efficacy of therapeutic drugs on chronic constipation

Scientific Title

A study to reveal the actual clinical features of chronic constipation and to evaluate the efficacy of therapeutic drugs on chronic constipation

Scientific Title:Acronym

A study to reveal the actual clinical features of chronic constipation and to evaluate the efficacy of therapeutic drugs on chronic constipation

Region

Japan


Condition

Condition

Chronic constipation

Classification by specialty

Gastroenterology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To explore the actual clinical features of chronic constipation. To evaluate the efficacy of therapeutic drugs on chronic constipation. To validate the newly developed questionnaire for chronic constipation, the Chronic Constipation-Therapeutic Efficacy and Satisfaction Test (CC-TEST).

Basic objectives2

Others

Basic objectives -Others

To study the effect of each constipation symptoms on patients' dairy life. To compare the efficacy of therapeutic drugs on chronic constipation among the groups divided by their mechanism of action. To examine the relationship between the patients' background factors and the clinical features of chronic constipation.

Trial characteristics_1

Exploratory

Trial characteristics_2

Pragmatic

Developmental phase

Not applicable


Assessment

Primary outcomes

The actual clinical features of chronic constipation explored by several questionnaires such as CC-TEST, Constipation Scoring System (CSS), Hospital Anxiety and Depression Scale (HADS), and Short Form-8 (SF-8). The efficacy of the therapeutic drugs on chronic constipation. The reliability and validity of the newly developed questionnaire for chronic constipation, CC-TEST. Outcome measures evaluation using questionnaires were performed at baseline, at 2 weeks and at 4 weeks after medication.

Key secondary outcomes

The effect of each constipation symptoms on patients' dairy life. Comparison of the efficacy of therapeutic drugs on chronic constipation among the groups divided by their mechanism of action. The relationship between the patients' background factors and the clinical features of chronic constipation.


Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

(1) Moderate or severe chronic constipation
(2) Age over 20 years old, any sex
(3) Spontaneous agreement of the said person
(4) Capable to understand the questionnaire

Key exclusion criteria

(1) Alarm feature such as vomiting, gastrointestinal tract bleeding, (includes hematemesis, bloody stool, anemia, etc.) or rapid weight loss
(2) History of gastrointestinal tract resection or vagotomy
(3) Any other disease or previous surgery which may influence the results of questionnaire more than chronic constipation
(4) Any organ failure or mental disease
(5) Confirmed or suspected malignancy
(6) Pregnancy, possible pregnancy, or breastfeeding
(7) Judged as irrelevant by the responsible doctor of this study

Target sample size

800


Research contact person

Name of lead principal investigator

1st name Koji
Middle name
Last name Nakada

Organization

The Jikei University Daisan Hospital

Division name

Department of Laboratory Medicine

Zip code

201-8601

Address

4-11-1, Izumihoncyo, Komae-shi, Tokyo, 201-8601 Japan

TEL

03-3480-1151

Email

nakada@jikei.ac.jp


Public contact

Name of contact person

1st name Koji
Middle name
Last name Nakada

Organization

The Jikei University Daisan Hospital

Division name

Department of Laboratory Medicine

Zip code

201-8601

Address

4-11-1, Izumihoncyo, Komae-shi, Tokyo, 201-8601 Japan

TEL

03-3480-1151

Homepage URL


Email

nakada@jikei.ac.jp


Sponsor or person

Institute

Others
Department of Laboratory Medicine, The Jikei University Daisan Hospital

Institute

Department

Personal name



Funding Source

Organization

The Japanese Gastroenterological Association

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization

Japan


Other related organizations

Co-sponsor


Name of secondary funder(s)

The Jikei University School of Medicine


IRB Contact (For public release)

Organization

The Ethics committee of The Jikei University School of Medicine for Biomedical Research

Address

3-25-8, Nishishinbashi, Minato-ku, Tokyo, 105-8461 Japan

Tel

03-3433-1111

Email

rinri@jikei.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

東京慈恵会医科大学附属第三病院(東京都)、一志胃腸科クリニック(東京都)、川崎医科大学附属病院(岡山県)、東京慈恵会医科大学附属病院(東京都)、東京慈恵会医科大学葛飾医療センター(東京都)、東邦大学医療センター大森病院(東京都)、愛知医科大学病院(愛知県)、九州大学医学部附属病院(福岡県)、平和台クリニック(東京都)、秋田大学医学部附属病院(秋田県)、日本医科大学付属病院(東京都)、順天堂大学医学部附属順天堂医院 (東京都)、やまもと消化器内科クリニック(東京都)、羽田バス通りクリニック(東京都)、名古屋市立大学病院(愛知県)、内山胃腸科(東京都)、横浜市立大学附属病院(神奈川県)、群馬大学医学部附属病院(群馬県)、京都府立医科大学附属病院(京都府)、大阪医科大学附属病院(大阪府)、鳥居内科クリニック(東京都)、帝京大学医学部附属病院(東京都)、ときとうクリニック(埼玉県)、日本医大武蔵小杉病院(神奈川県)、兵庫医科大学病院(兵庫県)、川村病院(静岡県)、渡辺胃腸科外科病院(岡山県)


Other administrative information

Date of disclosure of the study information

2019 Year 02 Month 13 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2019 Year 02 Month 13 Day

Date of IRB

2019 Year 04 Month 08 Day

Anticipated trial start date

2019 Year 05 Month 07 Day

Last follow-up date

2022 Year 02 Month 27 Day

Date of closure to data entry

2022 Year 03 Month 31 Day

Date trial data considered complete

2022 Year 04 Month 30 Day

Date analysis concluded

2022 Year 06 Month 30 Day


Other

Other related information

Multicenter prospective observational study
(1) Chronic Constipation-Therapeutic efficacy and Satisfaction Test (CC-TEST)
(2) Constipation Scoring System (CSS)
(3) Hospital Anxiety and Depression Scale (HADS)
(4) Short Form-8 (SF-8)
(5) Administered therapeutic drugs for chronic constipation during observation period
(6) Severity of chronic constipation
(7) Age
(8) Sex
(9) Height
(10) Body weight
(11) Activities of Daily Living (ADL)
(12) Illness period
(13) Consultation history of medical institution due to chronic constipation
(14) Coping or treatment for chronic constipation during the past month
(Food or Beverage / Supplement / Over-the-counter drugs / Prescription drugs
(15) History of abdominal surgery or Delivery
(16) Causal comorbidity of chronic constipation
(17) Causal prescription drugs of chronic constipation
And so on.


Management information

Registered date

2019 Year 02 Month 06 Day

Last modified on

2023 Year 02 Month 09 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000040776